SNOA
NASDAQ · Pharmaceuticals
Sonoma Pharmaceuticals Inc
$1.42
+0.17 (+13.60%)
Open$1.29
Previous Close$1.25
Day High$1.45
Day Low$1.23
52W High$6.92
52W Low$0.85
Volume—
Avg Volume201.4K
Market Cap6.78M
P/E Ratio—
EPS$-1.89
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+810.6% upside
Current
$1.42
$1.42
Target
$12.93
$12.93
$7.21
$12.93 avg
$14.12
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.33M | 48.65M | 1.82M |
| Net Income | -8,996,306 | -7,117,956 | 463.1K |
| Profit Margin | -16.3% | -15.5% | 25.4% |
| EBITDA | -6,579,509 | -5,494,974 | 609.2K |
| Free Cash Flow | — | — | 381.4K |
| Rev Growth | +13.8% | +13.8% | -7.1% |
| Debt/Equity | 0.07 | 0.07 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |